SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

NGL Fine-Chem informs about material impact of covid-19 pandemic

09 Jul 2020 Evaluate

NGL Fine-Chem has informed that pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 read with SEBI circular No: SEBI/HO/CFD/CMDI/CIR/P/2020/84 dated May 20, 2020, the disclosure of material impact of COVID-19 pandemic on the Company’s operation & performance is enclosed as Annexure-A.

The above information is a part of company’s filings submitted to BSE.

NGL Fine-Chem Share Price

3180.60 243.15 (8.28%)
03-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1904.65
Dr. Reddys Labs. 1374.55
Cipla 1458.45
Zydus Lifesciences 1141.00
Lupin 2476.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: